Daphne R. Friedman, MD
Department / Division
Medicine /
Medicine - Oncology
Address
DUMC 3872
Durham, NC 27710
Appointment Telephone
Not accepting patients
Office Telephone
919-684-8964
Fax Telephone
919-684-5325
- MD, University of Maryland School of Medicine, 2002
- Internal Medicine, University of Maryland Medical Center, 2002-2005
- Hematology and Medical Oncology, Duke University Medical Center, 2005-2008
Clinical Interests
Care of patients with hematologic cancers, research in improving treatment and outcomes in hematologic cancers, particularly chronic lymphocytic leukemia; research in survivorship issues
Research Interests
My area of expertise is in leukemias and lymphomas, specifically Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. My research interests are focused on improving treatment options for patients with hematologic malignancies, by 1) identifying promising new agents and testing them in the laboratory, 2) developing biomarkers that can predict treatment sensitivity and response, and 3) translating these findings into the clinic by performing clinical research trials.
This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
- Rhizen Pharmaceuticals
- TG Therapeutics
Representative Publications
Friedman, DR; Weinberg, JB; Barry, WT; Goodman, BK; Volkheimer, AD; Bond, KM; Chen, Y; Jiang, N; Moore, JO; Gockerman, JP; Diehl, LF; Decastro, CM; Potti, A; Nevins, JR. A genomic approach to improve prognosis and predict therapeutic response in chronic lymphocytic leukemia. Clinical Cancer Research. 2009;15:6947-6955.
(2009)
Abstract
Zhang, J; Jima, DD; Jacobs, C; Fischer, R; Gottwein, E; Huang, G; Lugar, PL; Lagoo, AS; Rizzieri, DA; Friedman, DR; Weinberg, JB; Lipsky, PE; Dave, SS. Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood. 2009;113:4586-4594.
(2009)
Abstract
Weinberg, JB; Volkheimer, AD; Chen, Y; Beasley, BE; Jiang, N; Lanasa, MC; Friedman, D; Vaccaro, G; Rehder, CW; Decastro, CM; Rizzieri, DA; Diehl, LF; Gockerman, JP; Moore, JO; Goodman, BK; Levesque, MC. Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia. American Journal of Hematology. 2007;82:1063-1070.
(2007)
Abstract
